Trending Now
Canadian Biotech Disruptor Lexston Life Sciences is unlocking the God Molecule...
Investors were all spooked today with Dow plummeting more than 500 points. The primary cause can be attributed to inflation fears, disappointing...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Alnylam Pharmaceuticals, Inc. (ALNY): Pioneering RNAi Therapeutics with Vutrisiran Expansion
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a trailblazer in RNAi therapeutics, closed at $237.97 on December 27, marking a modest decline of 1.87%...
MAKE IT MODERN
LATEST REVIEWS
ImmunityBio’s (IBRX) Latest Financial Outlook and Medical Innovation Spotlight: A Glimpse...
In the dynamic world of biotech investments, ImmunityBio Inc. (NASDAQ: IBRX) showcases a steady financial outlook as projected by Wall Street analysts....
MAKE IT MODERN
PERFORMANCE TRAINING
Titan Pharmaceuticals Inc.’s (NASDAQ:TTNP) Partner Enters Exclusive Commercialization agreement For Probuphine In EU with...
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has announced that it's Molteni Farmaceutici partner has signed an exclusive commercialization agreement with Accord Healthcare for Sixmo®, which is...
TG Therapeutics Inc. (NASDAQ:TGTX) Presents Triple Combination Data At 62nd American Society of Haematology...
TG Therapeutics Inc. (NASDAQ:TGTX) has announced two triple combination data presentation. The company’s first presentation evaluated the experimental combination of umbralisib and...
Where is ADMA Biologics Inc ($ADMA) headed next ?
In a recent close of the trading day, ADMA Biologics, Inc. (ADMA) showcased a notable rise, closing at $11.00, which marked an...
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Receives Marketing Authorization For Firdapse To Cure Patients With LEMS:...
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) received marketing authorization for Firdapse from Health Canada to treat patients with LEMS (Lambert-Eaton myasthenic syndrome) in Canada.
Marketing authorization under...
Chemomab Therapeutics Ltd. (NASDAQ: CMMB) Announces Findings Supporting Use of CM-101 as A Systemic...
Chemomab Therapeutics Ltd. (NASDAQ: CMMB) has reported two scientific presentations, including patient and preclinical findings supporting the possible use of its lead treatment candidate,...
MAKE IT MODERN
